<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Presseportal.de - Servier Laboratories</title>
    <link>http://www.presseportal.de/pm/70043/servier_laboratories/</link>
    <description>Presseportal.de: Servier Laboratories (Digitale Pressemappe)</description>
    <language>de-de</language>
    <copyright>news aktuell GmbH</copyright>
    <managingEditor>redaktion@presseportal.de</managingEditor>
    <pubDate>Mon, 22 Mar 2010 00:00:01 +0100</pubDate>
    <lastBuildDate>Mon, 16 Jun 2008 16:51:00 +0200</lastBuildDate>
    <category></category>
    <ttl>6</ttl>
    <image>
      <url>http://www.presseportal.de/images/logo_napresseportal.gif</url>
      <title>Presseportal.de</title>
      <link>http://www.presseportal.de/pm/70043/servier_laboratories/</link>
    </image>
                                                          <item>
        <title>Preterax(R) Prevents and Reverses Renal Disease in Type 2 Diabetics</title>
        <guid>http://www.presseportal.de/pm/70043/1211794/servier_laboratories/rss</guid>
        <description>Servier Laboratories: Berlin (ots/PRNewswire) - New results of the ADVANCE (Action in Diabetes and Vascular disease: PreterAx and DiamicroN-MR Controlled Evaluation) trial have been presented today at the European Society of Hypertension (ESH) and show that the antihypertensive Preterax - a fixed combination of the ACE-inhibitor perindopril and the diuretic indapamide - reduces the likelihood of new or worsening nephropathy (kidney damage) in patients ...</description>
        <content:encoded><![CDATA[<b>Servier Laboratories</b> [<a href="http://www.presseportal.de/pm/70043/servier_laboratories/rss">Pressemappe</a>]<br>
                            Berlin (ots/PRNewswire) - New results of the ADVANCE (Action in Diabetes and Vascular disease: PreterAx and DiamicroN-MR Controlled Evaluation) trial have been presented today at the European Society of Hypertension (ESH) and show that the antihypertensive Preterax - a fixed combination of the ACE-inhibitor perindopril and the diuretic indapamide - reduces the likelihood of new or worsening nephropathy (kidney damage) in patients ...
            <a href="http://www.presseportal.de/pm/70043/1211794/servier_laboratories/rss">Lesen Sie hier weiter...</a>
        <br clear="all" /><IMG SRC="http://presspor.ivwbox.de/cgi-bin/ivw/CP/de_1003" WIDTH="1" HEIGHT="1">]]></content:encoded>
        <link>http://www.presseportal.de/pm/70043/1211794/servier_laboratories/rss</link>
        <category>Wirtschaft</category>
        <pubDate>Mon, 16 Jun 2008 16:51:00 +0200</pubDate>
        <author>redaktion@presseportal.de</author>
        <source url="http://www.presseportal.de/pm/70043/1211794/servier_laboratories/rss">Servier Laboratories</source>
        </item>
                                                          <item>
        <title>Major International Diabetes Study Does not Confirm Increased Risk of Death Reported by US Trial</title>
        <guid>http://www.presseportal.de/pm/70043/1136202/servier_laboratories/rss</guid>
        <description>Servier Laboratories: Paris (ots/PRNewswire) - - Preliminary Findings from the Largest-Ever Study of Treatments for Diabetes Provide no Evidence That Intensive Treatment to Lower Blood Glucose (Sugar) Increases Risk of Death Interim results from the ...</description>
        <content:encoded><![CDATA[<b>Servier Laboratories</b> [<a href="http://www.presseportal.de/pm/70043/servier_laboratories/rss">Pressemappe</a>]<br>
                            Paris (ots/PRNewswire) - - Preliminary Findings from the Largest-Ever Study of Treatments for Diabetes Provide no Evidence That Intensive Treatment to Lower Blood Glucose (Sugar) Increases Risk of Death Interim results from the ...
            <a href="http://www.presseportal.de/pm/70043/1136202/servier_laboratories/rss">Lesen Sie hier weiter...</a>
        <br clear="all" /><IMG SRC="http://presspor.ivwbox.de/cgi-bin/ivw/CP/de_1003" WIDTH="1" HEIGHT="1">]]></content:encoded>
        <link>http://www.presseportal.de/pm/70043/1136202/servier_laboratories/rss</link>
        <category>Wirtschaft</category>
        <pubDate>Thu, 14 Feb 2008 12:49:00 +0200</pubDate>
        <author>redaktion@presseportal.de</author>
        <source url="http://www.presseportal.de/pm/70043/1136202/servier_laboratories/rss">Servier Laboratories</source>
        </item>
      </channel>
</rss>